This SNO 2025 presentation represents the second abstract from Rakovina Therapeutics at the conference and reflects the ...

INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, will be showcased in three presentations, including new Phase 1 monotherapy and combination data in ...

LOS ANGELES -The UCLA Center for India and South Asia (CISA) has announced its Call for Papers for the Tenth Annual Graduate ...

(MENAFN- GlobeNewsWire - Nasdaq) Oral presentation of biomarker data shows RP1 plus nivolumab reverses multiple resistance mechanisms to PD-1 blockade in advanced melanoma following definitive anti-PD ...

Jefferies London Healthcare Conference 2025 November 18, 2025 6:00 AM ESTCompany ParticipantsWilliam Meury - CEO, President ...

Adaptive Biotechnologies (ADPT) announced that its next-generation sequencing-based clonoSEQ test for measurable residual disease assessment will be included in 89 abstracts, including 36 oral ...

Dr S.V.S. Narayana Murty, vice-president of the IIM and CMD of Midhani (Mishra Dhatu Nigam), said, the events would set the ...

The University of Guam strengthened its presence in STEM at the 2025 Society for Advancement of Chicanos/Hispanics and Native ...

PMB-CT01 is a first-in-class BAFF-R–targeted autologous CAR T cell therapy. BAFF-R is expressed almost exclusively on B cells and is essential for B-cell survival, reducing the likelihood of ...

NEW YORK, Nov. 16, 2025 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD), today announced new ...

Media and information are not abstract fields but strategic tools that encompass memory, identity, and resilience, according ...

A bid by host nation Brazil to establish a "road map" for the world's phaseout of fossil fuels did not materialize ...